Introduction/Overview Nausea and vomiting are complex physiological responses coordinated by the central nervous system, often serving as protective reflexes to expel ingested toxins. In clinical practice, however, these symptoms represent significant adverse effects of numerous medical treatments, including chemotherapy and surgery, and are primary manifestations of various disease states. The effective management of nausea and … Read more
Introduction/Overview Proton pump inhibitors (PPIs) represent a cornerstone class of therapeutic agents in the management of acid-related disorders. Since the introduction of omeprazole in the late 1980s, these drugs have largely superseded histamine H2-receptor antagonists as the most potent and reliable means of suppressing gastric acid secretion. Their development marked a significant advancement in gastroenterology, … Read more
Introduction/Overview Proton pump inhibitors represent a cornerstone class of therapeutic agents in the management of acid-related disorders. Since the introduction of omeprazole in the late 1980s, these drugs have largely superseded histamine Hโ-receptor antagonists as the most effective means of achieving sustained gastric acid suppression. Their development marked a significant advancement in gastroenterological pharmacotherapy, offering … Read more
Introduction/Overview Proton pump inhibitors represent a cornerstone class of therapeutic agents in the management of acid-related disorders. Since their introduction in the late 1980s, these drugs have revolutionized the treatment of conditions characterized by gastric acid hypersecretion, offering superior efficacy and duration of acid suppression compared to preceding therapies like histamine H2-receptor antagonists. The clinical … Read more
Introduction/Overview Peptic ulcer disease (PUD) represents a common clinical condition characterized by a breach in the mucosal lining of the stomach or duodenum, extending through the muscularis mucosa. The pathophysiology involves an imbalance between aggressive factors, primarily gastric acid and pepsin, and defensive mucosal mechanisms. The pharmacological management of PUD has evolved significantly, shifting from … Read more
Introduction/Overview Peptic ulcer disease (PUD) represents a common clinical condition characterized by a breach in the mucosal lining of the stomach or duodenum, extending through the muscularis mucosae. The pathophysiology involves an imbalance between aggressive factors, primarily gastric acid and pepsin, and defensive mucosal mechanisms. The pharmacological management of PUD has undergone a significant evolution, … Read more
Introduction/Overview Cough is a complex, protective reflex mediated by the vagus nerve, serving to clear the airways of secretions, irritants, and foreign particles. While essential for pulmonary defense, cough can become excessive, non-productive, and debilitating, significantly impairing quality of life, sleep, and recovery. The pharmacological management of cough involves two principal strategies: suppression of the … Read more
1. Introduction/Overview Cough is a complex, protective reflex action mediated by the cough center in the medulla oblongata and involving afferent and efferent neural pathways. While essential for airway clearance, persistent or non-productive cough can significantly impair quality of life, disrupt sleep, and exacerbate underlying conditions. The pharmacological management of cough involves two principal strategies: … Read more
1. Introduction/Overview Chronic obstructive pulmonary disease (COPD) represents a significant global health burden, characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. The pharmacological management of COPD is a cornerstone of treatment, aimed at reducing symptoms, decreasing the frequency and severity of exacerbations, and improving health status and exercise tolerance. … Read more
1. Introduction/Overview Chronic Obstructive Pulmonary Disease (COPD) represents a significant global health burden characterized by persistent respiratory symptoms and airflow limitation due to airway and alveolar abnormalities, typically caused by significant exposure to noxious particles or gases. The pharmacological management of COPD is a cornerstone of therapy aimed at reducing symptoms, decreasing the frequency and … Read more